EQS-News: Cantourage Group SE / Key word(s): Product Launch Cantourage Group SE sets corporate record: four new cultivation partners within a month 29.06.2023 / 11:47
Heidelberg Pharma AG / Key word(s): Miscellaneous Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics 29-Jun-2023 / 09:45 CET/CEST Disclosure of an inside information acc.
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 29.06.2023 / 09:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed
EQS-News: Formycon AG / Key word(s): Regulatory Admission Formycon announces submission of the biologics license application (BLA) for FYB203, an aflibercept biosimilar candidate to the
EQS-News: PharmaSGP Holding SE / Key word(s): AGM/EGM PharmaSGP Holding SE: Strong support at 2023 AGM for very successful business development 29.06.2023 / 07:30 CET/CEST
Comparing psychedelics Talk to any psychonaut and they will tell you there are (significant) differences between LSD, psilocybin, and mescaline. Look at brain scans and
Greenlane Holdings, Inc. Announces $4 Million Public Offering BOCA RATON, FL / ACCESSWIRE / June 29, 2023 / Greenlane Holdings, Inc. (“Greenlane” or the “Company”)
The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder. The treatment,
Patients fast before surgery to prevent food from getting into their lungs while they’re under — a serious concern that can lead to lung infection.
Cyanotriazole compounds are fast-acting topoisomerase II poisons that can selectively and rapidly kill trypanosome parasites that cause Chagas disease and African sleeping sickness, according to